PHILADELPHIA — Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR) will provide opening remarks and serve as a panelist during a special symposium, “Bridging the Gap in Ovarian Cancer,” hosted by the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, Tuesday, Sept. 16.
The symposium, to begin at 1 p.m. ET, is a free public event geared toward ovarian cancer patients, survivors, family members, advocates, researchers, and other interested members of the public. The Koch Institute organized the event to discuss advances in the science and technology to fight ovarian cancer and will highlight the power of bringing together bioengineering, advanced cancer science, and clinical oncology to solve the most challenging problems in ovarian cancer.
Foti will provide the opening remarks at 2 p.m. The symposium will provide a clinician’s perspective on challenges associated with ovarian cancer and presentations from MIT faculty on their research on novel approaches for the detection and treatment of ovarian cancer, as well as advocacy showcases, tours, a roundtable discussion, and reception. Presenters and panelists include scientists, survivors, and advocates.
Additionally, Foti will be one of three featured speakers at the evening program, “SOLUTIONS with/in/sight: Women Converge on Cancer.” Foti will join two other women who are advocates for cancer research: Susan Hockfield, PhD, MIT president emerita and Koch Institute faculty member, and Joyce Kulhawik, three-time cancer survivor and Emmy award-winning arts and entertainment critic. These evening talks begin at 7 p.m.
For more information or to register for the symposium and/or evening program, visit the Koch Institute’s website here: https://ki.mit.edu/news/events/ocsept2014.
# # #
Follow us: Cancer Research Catalyst https://blog.aacr.org; Twitter @AACR; and Facebook https://www.facebook.com/aacr.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in 97 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with over 18,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org.
